HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

10-methoxy-9-nitrocamptothecin

has antineoplastic activity; structure in first source

Also Known As:

MONCPT cpd

Networked: 3 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Camptothecin: 2033
    - 10-methoxy-9-nitrocamptothecin: 3

Experts

1.	Yang, Bo: 3 articles (03/2010 - 04/2009)
2.	Zhang, Chong: 2 articles (03/2010 - 12/2009)
3.	Zhu, Hong: 2 articles (03/2010 - 12/2009)
4.	He, Qiao-Jun: 2 articles (12/2009 - 04/2009)
5.	He, Qiaojun: 1 article (03/2010)
6.	Lou, Jianshu: 1 article (03/2010)
7.	Lu, Wei: 1 article (03/2010)
8.	Yang, Xiaochun: 1 article (03/2010)
9.	Zhu, Difeng: 1 article (03/2010)
10.	Jiang, Hai: 1 article (12/2009)

Related Diseases

1.

Neoplasms (Cancer)

04/01/2009 - "An oil/water nanoemulsion was developed in the present study to enhance the solubility, stability and anti-tumor activity of a novel 10-methoxy-9-nitrocamptothecin (MONCPT). "
03/01/2010 - "In previous research, we found that 10-methoxy-9-nitrocamptothecin (MONCPT) possessed potent anti-tumor activity in A549 cells in vitro and in vivo. "
12/01/2009 - "The potent anti-cancer capability of a novel CPT derivarate, 10-methoxy-9-nitrocamptothecin (MONCPT), has been demonstrated in our previous studies. "

Related Drugs and Biologics

1.	2- cyclohexylidenhydrazo- 4- phenyl- thiazole